Coś na depresje - p.Ambroziak mile widziany, Grasik też ;)

Witam. Chcialbym dowiedziec sie, za pomoca jakich suplementow, zywnosci, skladnikow diety czy innych substancji mozna wplynac na zanik depresji? Jak dotad slyszalem, ze dobrze dzialaja np.:
omega-3, zielona herbata, zen-szen, magnez, lecytyna.
Stosowalem niedawno wyciag z dziurawca i wydaje mi sie ze nasilil on stany lekowe! Bralem tez ALC i nic nie pomoglo.
Natomiast nie chce siegac po 'ciezsze' leki typu prozac.
Bede bardzo wdzieczny za wartosciowe, nawet trudne pod wzgledem nomenklatury odpowiedzi.
Pozdrawiam!

yyyyyyyy
wez sie ogarnij, zacznij wysypiać i dobrze odzywiac, do tego suple juz napisali, ZMA tez sie przyda ...
tez troche tak świrowałem od duzej ilosci i długo stosowanych procgow przeciwobolowych/zapalnych...-mineło troche

Jakie dawki ALC brałeś ?

srednio ok. 1g/dzien przez 2 tyg.

phenibut

zdecydowanie omega 3 i to mozna stosowac duze dawki
ostatnio wpadlo mi przed oczy badanie iz osoby o sklonnosciach pedofilskich maja niski poziom DHA i omega 3 w organizmie

dzieki Tyce -

Lower omega-3 polyunsaturated fatty acids and lower docosahexaenoic acid in men
with pedophilia.

Mincke E, Cosyns P, Christophe AB, De Vriese S, Maes M.

Department of Psychiatry, Antwerp Forensic Center, University of Antwerp,
Edegem, and Department of Internal Medicine, Ghent University Hospital, Belgium.

BACKGROUND: Previous studies have suggested that abnormalities in plasma
phospholipid fatty acids may play a role in aggressive behavior. Recently, it
was suggested that a dysfunctional serotonergic turnover in the brain may be involved in the etiopathology of pedophilia. Depletion of n-3 polyunsaturated fatty acids (PUFA) may cause alterations in the serotonergic system that may be related to pedophilia and aggression. METHODS: This study examines the serum phospholipid n-3 and n-6 PUFA fractions in pedophilia. Twenty-seven pedophilic men and eighteen healthy volunteers participated in this study.

RESULTS: In pedophilia there was a significant depletion of the C22:6n-3 (docosahexaenoic acid, DHA), total n-3 fractions and an increase in the total n-6/n-3 and C20:4n-6/C20:5n-3 (arachidonic acid/eicosapentaenoic acid) ratios. Using the NEO Personality Inventory, lower DHA in pedophiles is related to more impulsiveness and lower agreeableness (trust, altruism, straightforwardness, compliance) and
conscientiousness (self-discipline).

CONCLUSIONS: The results of this study
suggest that a depletion of the serum phospholipid n-3 higher unsaturated fatty acids (HUFAs) and, in particular, of DHA may take part in the pathophysiology of pedophilia. One hypothesis is that a depletion of n-3 HUFAs and DHA may cause alterations in the serotonergic turnover, which are related to impulse discontrol and aggression-hostility, behaviors which are associated with pedophilia.


oraz slonce - czyli naturalna wit D to dwa najlepsze srodki w tym przydku i to NIE szkodliwe :D

reszte musialbym posledzic bo nie rzucilo mi sie w tym aspekcie w oczy - fakt ze nigdy nie szukalem tego aspektu :D

Mozesz spróbowac Deprim. Nie jest hardcorowy i jest bez recpety. W dodatku ludzie go chwala. ALC w duzych dawkach
Czekolada i Solarium tez pomaga.

To są jednak srodki na "dołki" psychiczne. Depresja to mocne słowo. Depresje leczy psychiatra to choroba jak kazda inna.

Omega3 na depresje

Zmieniony przez - Bahamut w dniu 2007-03-05 18:58:46

Dokładnie. Deprim nie jest zły na zniżki formy. Depresja to dość mocne słowo (i czasem IMO nadużywane).

Docosahexanoic acid and omega-3 fatty acids in depression.
Mischoulon D, Fava M.

Depression Clinical and Research Program, Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.

Geographic areas where consumption of DHA is high are associated with decreased rates of depression. DHA deficiency states, such as alcoholism and the postpartum period, also are linked with depression. Individuals with major depression have marked depletions in omega-3 FAs (especially DHA) in erythrocyte phospholipids compared with controls. These data suggest that DHA may be associated with depression, and the limited data available on supplementation with DHA or other omega-3 FAs seem to support the hypothesis that DHA may have psychotropic effects. Overall, the use of EFAs is promising, particularly in view of the many illnesses potentially treatable with these substances; however, larger, carefully designed studies are needed to establish whether DHA is an effective and safe antidepressant, mood stabilizer, or antipsychotic. A few preliminary trials of DHA are in progress, but no studies comparing DHA against placebo or against an established antidepressant have been carried out. Studies to address this issue are being developed at the Massachusetts General Hospital. Studies likely will require escalating doses of DHA, eventually reaching high levels so as to ensure that patients will avoid a potentially ineffective subclinical dose. Careful monitoring of dietary intake among subjects also will necessary because a high intake of omega-3-rich foods may confound results. Finally, large-scale, placebo-controlled, double-blind trials comparing the efficacy and safety of DHA against standard antidepressants are required before psychiatrists can recommend DHA therapy as effective and safe for the treatment of depression and other mood disorders. Given the popularity of self-medication by patients who already are taking marketed antidepressants, studies examining the use of DHA as an augmentor to standard antidepressants may answer whether DHA can occupy a niche as an augmenting agent for patients who have made a partial response or have not responded to conventional antidepressants. Considering that natural medications generally seem best for treating mild to moderate illness, the role of DHA as a therapy for minor and subsyndromal depression also should be considered. It is hoped that studies of these types will help to clarify some of the knowledge gaps outlined in this article.


fakt ze w przypadku glebokich depresji juz tak dobrze nie ma

A Double-Blind, Placebo-Controlled Study of the Omega-3 Fatty Acid Docosahexaenoic Acid in the Treatment of Major Depression
Lauren B. Marangell, M.D., James M. Martinez, M.D., Holly A. Zboyan, B.A., Barbara Kertz, M.A., H. Florence Seung Kim, M.D. and Lucy J. Puryear, M.D.

OBJECTIVE: This study was an evaluation of the omega-3 fatty acid docosahexaenoic acid (DHA) for the treatment of major depression. METHOD: Thirty-six depressed patients were randomly assigned to receive DHA, 2 g/day, or placebo for 6 weeks. Response was defined a priori as a 50% reduction in the score on the Montgomery-Åsberg Depression Rating Scale. Thirty-five participants were evaluable; 18 received DHA, and 17 received placebo. RESULTS: Response rates were 27.8% in the DHA group and 23.5% in the placebo group. The difference in response rates between groups did not reach statistical significance. CONCLUSIONS: This trial failed to show a significant effect of DHA monotherapy in subjects with major depression.

jednak glebokie w moim odczuciu niemedycznym nie wystepuja w sposob masowy

Omega-3 fatty acids in the treatment of psychiatric disorders.
Peet M, Stokes C.

Swallownest Court Hospital, Doncaster and South Humber Healthcare NHS Trust, Sheffield, UK. [email protected]

The importance of omega-3 fatty acids for physical health is now well recognised and there is increasing evidence that omega-3 fatty acids may also be important to mental health. The two main omega-3 fatty acids in fish oil, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) have important biological functions in the CNS. DHA is a major structural component of neuronal membranes, and changing the fatty acid composition of neuronal membranes leads to functional changes in the activity of receptors and other proteins embedded in the membrane phospholipid. EPA has important physiological functions that can affect neuronal activity. Epidemiological studies indicate an association between depression and low dietary intake of omega-3 fatty acids, and biochemical studies have shown reduced levels of omega-3 fatty acids in red blood cell membranes in both depressive and schizophrenic patients.Five of six double-blind, placebo-controlled trials in schizophrenia, and four of six such trials in depression, have reported therapeutic benefit from omega-3 fatty acids in either the primary or secondary statistical analysis, particularly when EPA is added on to existing psychotropic medication. Individual clinical trials have suggested benefits of EPA treatment in borderline personality disorder and of combined omega-3 and omega-6 fatty acid treatment for attention-deficit hyperactivity disorder. The evidence to date supports the adjunctive use of omega-3 fatty acids in the management of treatment unresponsive depression and schizophrenia. As these conditions are associated with increased risk of coronary heart disease and diabetes mellitus, omega-3 fatty acids should also benefit the physical state of these patients. However, as the clinical research evidence is preliminary, large, and definitive randomised controlled trials similar to those required for the licensing of any new pharmacological treatment are needed.

A co z wysilkiem fizycznym?Jest?
Tez zwieksza wydzielanie endorfin

tylko komu sie chce cwiczyc skoro ma depresje albo zalamke ??